XZXingliao Zhang

Xingliao Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Xingliao Zhang has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Zhao

    Research Centre for Translational Medicine at East Hospital, School of Life Science and Technology, Tongji University, Shanghai, China

    1 shared publication
  • Jing Zhang

    Research Center for Translational Medicine at East Hospital, School of Life Science and Technology, Tongji University, Shanghai, 200092, China.

    1 shared publication
  • Jun Zhang

    Research Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China

    1 shared publication
  • Shoutao Lu

    Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Stem Cell Translational Research Center of Tongji Hospital, Tongji University School of Medicine, Tongji University, Shanghai, People's Republic of China

    1 shared publication
  • Wanting Zhang

    Department of Mathematics and Applied Mathematics (Teacher Training), Yanbian University, Yanji, Jilin Province, China

    1 shared publication
  • Yang Zhou

    Tongji University School of Medicine

    1 shared publication

Latest Publications

  • Human Exosomes Accelerate Cutaneous Wound Healing by Promoting Collagen Synthesis in a Diabetic Mouse Model

    by Bo Zhao, Xingliao Zhang, Yuan Lin Zhang, Yijun Lu, Wanting Zhang, Shoutao Lu, Yu Fu, Yang Zhou, Jun Zhang, Jing Zhang

    Chronic wounds including diabetic foot ulcers are clinical emergencies that need careful management. Exosomes from human adipose-derived mesenchymal stem cells (hADSCs) are a new promising cell-free therapy for the regeneration of dermal wounds. We established a delayed wound healing model using diabetic female mice. A 1.5 cm2 full-thickness cutaneous wound was made ventrally in 6-week-old db/db mice. After treatment with PBS, rhEGF, hADSCs-CM, or hADSCs-Ex three times a day for 2 weeks, we measured wound healing closure rates and performed histological analysis. Human dermal fibroblasts (WS1) were evaluated by PKH26-Exo co-localization test, CCK-8 test, cell scratch test, as well as the transwell test, while the expression of MMP1, MMP3, Collagen I, and Collagen III were analyzed by RT-qPCR and western blot. Wound closure and re-epithelialization were accelerated by hADSCs-Ex. Besides, hADSCs-Ex enhanced skin collagen production, angiogenesis, cell proliferation, inhibited apoptosis, promoted skin barrier function repair, and reduced inflammation in skin lesions. Furthermore, negative regulation of MMP1 and MMP3 enhanced collagen synthesis wound healing-promoting effects of hADSCs-Ex. hADSCs-Ex treatment for diabetic wounds was provided a novel cell-free therapeutic strategy.